17 results
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... ., 4 mg/kg on days ... dose of 20–60 mg/kg ... ., 4 mg/kg on days ... infections #HIVAIDS #pharmacology
Multifocal (or multiform) atrial tachycardia (MAT) is an abnormal heart rhythm, specifically a type of supraventricular
sinoatrial node (SA ... outside of the SA ... Clinical #MedStudent #EKG ... MultifocalAtrialTachycardia #ECGEducator
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... amphotericin B, 3 to 5 mg/kg ... Penicilliosis #IDSA ... infections #HIVAIDS #pharmacology
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
• Flex-Sig: If ... Tx Management (IDSA ... Bezlotoxumab 10 mg/kg ... /severe CDI IDSA ... infectiousdiseases #IDSA
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Benznidazole 5–8 mg/kg ... Nifurtimox 8–10 mg/kg ... Trypanosomiasis #IDSA ... infections #HIVAIDS #pharmacology
A wandering atrial pacemaker, (WAP), is an atrial arrhythmia that occurs when the natural cardiac pacemaker
sinoatrial node (SA ... pacemaker from the SA ... identifiable on ECG ... Clinical #MedStudent #EKG ... WanderingAtrialPacemaker #ECGEducator
IDSA - Diabetic Foot Infections - Suggested Route, Setting, and Duration of Antibiotic Therapy, by Clinical
IDSA - Diabetic ... infected tissue (eg ... postoperatively ≥3 mo #IDSA ... #antibiotics #pharmacology
A junctional escape beat is a delayed heartbeat originating not from the atrium but from an
impulses from the SA ... node because of SA ... function when the SA ... Clinical #MedStudent #EKG ... JunctionalEscape #ECGEducator
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... amphotericin B 3–5 mg/kg ... deoxycholate 0.7–1.0 mg/kg ... Coccidiodomycosis #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... acyclovir 5 mg/kg ... HerpesSimplex #HSV #IDSA ... infections #HIVAIDS #pharmacology